Inventor · disambiguated record
Alexandre Joseph Buckmelter
Also filed as: BUCKMELTER ALEXANDRE · BUCKMELTER ALEXANDRE J · BUCKMELTER ALEXANDRE JOSEPH
54 granted patents·14 pending applications·460 citations·filing 2003–2022
99Inventor score
Files withFORMA THERAPEUTICS INC25ARRAY BIOPHARMA INC9FORMA TM LLC7VALO EARLY DISCOVERY INC7VALO HEALTH INC7
Top patents by PatentIndex Score
68 records- 0197US9840491B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Dec 12, 2017·22 cites·17 claims
- 0296US10377767B2Thienopyrimidinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·16 cites·16 claims
- 0396US10377773B2Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·18 cites·16 claims
- 0496US10000495B2Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Jun 19, 2018·21 cites·16 claims
- 0596US9938300B2Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Apr 10, 2018·23 cites·15 claims
- 0696US9932351B2Thienopyrimidinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Apr 3, 2018·24 cites·12 claims
- 0796US9902728B2Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Feb 27, 2018·24 cites·40 claims
- 0895US10934299B2Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Mar 2, 2021·7 cites·20 claims
- 0995US10772874B2Compounds and compositions for the inhibition of NAMPTFORMA TM LLC·Filed 2019·Granted Sep 15, 2020·6 cites·11 claims
- 1095US10377760B2Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·17 cites·20 claims
- 1195US10351571B2Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Jul 16, 2019·15 cites·17 claims
- 1295US7777032B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2009·Granted Aug 17, 2010·11 cites·2 claims
- 1395US7585975B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Sep 8, 2009·11 cites·16 claims
- 1494US10519129B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·8 cites·21 claims
- 1594US10519127B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·8 cites·24 claims
- 1694US10519130B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·8 cites·21 claims
- 1794US10519128B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·8 cites·19 claims
- 1894US10513507B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2017·Granted Dec 24, 2019·9 cites·20 claims
- 1994US10513508B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 24, 2019·8 cites·30 claims
- 2094US10508098B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 17, 2019·8 cites·20 claims
- 2194US9676721B2Compounds and compositions for the inhibition of NAMPTBAIR KENNETH W·Filed 2011·Granted Jun 13, 2017·33 cites·7 claims
- 2293US10906916B2Thienopyrimidinones as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Feb 2, 2021·4 cites·16 claims
- 2393US10647695B2Compounds and compositions for the inhibition of NAMPTFORMA TM LLC·Filed 2019·Granted May 12, 2020·5 cites·7 claims
- 2493US10272072B2Compounds and compositions for the inhibition of NAMPTFORMA TM LLC·Filed 2016·Granted Apr 30, 2019·11 cites·19 claims
- 2592US9169209B2Compounds and compositions for the inhibition of NAMPTBAIR KENNETH W·Filed 2011·Granted Oct 27, 2015·25 cites·22 claims
- 2691US11547701B2Compounds and compositions for the inhibition of NAMPTVALO HEALTH INC·Filed 2020·Granted Jan 10, 2023·2 cites·11 claims
- 2791US11279687B2Compounds and compositions for the inhibition of NAMPTVALO HEALTH INC·Filed 2020·Granted Mar 22, 2022·2 cites·9 claims
- 2891US10456382B2Compounds and compositions for the inhibition of NAMPTFORMA TM LLC·Filed 2018·Granted Oct 29, 2019·7 cites·20 claims
- 2991US10329275B2Compounds and compositions for the inhibition of NAMPTFORMA TM LLC·Filed 2018·Granted Jun 25, 2019·8 cites·10 claims
- 3090US9676791B2Quinazoline analogs as receptor tyrosine kinase inhibitorsWALLACE ELI·Filed 2012·Granted Jun 13, 2017·5 cites·9 claims
- 3190US9555039B2Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT)BAIR KENNETH W·Filed 2011·Granted Jan 31, 2017·13 cites·19 claims
- 3289US7501427B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2003·Granted Mar 10, 2009·14 cites·37 claims
- 3388US11247987B2Inhibiting ubiquitin specific peptidase 30FORMA THERAPEUTICS INC·Filed 2018·Granted Feb 15, 2022·3 cites·24 claims
- 3488US10836741B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Nov 17, 2020·3 cites·28 claims
- 3587US10927130B2Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Feb 23, 2021·4 cites·16 claims
- 3685US11479564B2Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT)VALO HEALTH INC·Filed 2020·Granted Oct 25, 2022·1 cites·7 claims
- 3785US10981915B2Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Apr 20, 2021·3 cites·12 claims
- 3884US10221194B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Mar 5, 2019·2 cites·1 claims
- 3983US12336981B2Compounds and compositions for the inhibition of NAMPTVALO HEALTH INC·Filed 2022·Granted Jun 24, 2025·0 cites·11 claims
- 4083US10399980B2Purinones as ubiquitin-specific protease 1 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Sep 3, 2019·2 cites·11 claims
- 4183US10189841B2Purinones as ubiquitin-specific protease 1 inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Jan 29, 2019·3 cites·11 claims
- 4282US8278314B2Quinazoline analogs as receptor tyrosine kinase inhibitorsWALLACE ELI·Filed 2008·Granted Oct 2, 2012·6 cites·14 claims
- 4381US11161848B2Purinones as ubiquitin-specific protease 1 inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Nov 2, 2021·1 cites·26 claims
- 4481US10696692B2Amido-benzyl sulfone and sulfoxide derivatesFORMA TM LLC·Filed 2013·Granted Jun 30, 2020·6 cites·4 claims
- 4581US7452895B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2004·Granted Nov 18, 2008·14 cites·17 claims
- 4678US2023110003A1Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (nampt)VALO HEALTH INC·Filed 2022·Application pending·0 cites
- 4777US8394795B2Pyrazole [3, 4-B] pyridine Raf inhibitorsAHRENDT KATERI A·Filed 2009·Granted Mar 12, 2013·5 cites·45 claims
- 4877US2021269455A1Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 4976US11739071B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2020·Granted Aug 29, 2023·0 cites·20 claims
- 5076US8338452B2Raf inhibitor compounds and methods of use thereofAHRENDT KATERI A·Filed 2009·Granted Dec 25, 2012·4 cites·49 claims
Showing the top 50 of 68 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →